Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Comera Life Sciences Holdings, Inc.CMRA · Entity 94670 | Director | August 31, 2023 | September 01, 2023 |
| Decoy Therapeutics Inc.FLKS · Entity 937 | Director | July 25, 2018 | July 26, 2018 |
| TELEFLEX INCTFX · Entity 3798 | Director | June 07, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Comera Life Sciences Holdings, Inc.
Report date August 31, 2023 · Filed September 01, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.70 · Expires 2033-08-10 | Direct | 96,378 |
Reported balance
After 2023-08-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-08-31 · Grant · Acquired 96,378 · Balance 96,378 F1: The option grant was approved by the registrant's board of directors on August 10, 2023, subject to stockholder approval of an amendment to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the "Plan") under which the option was granted. The registrant's stockholders approved the Plan amendment on August 31, 2023. F3: In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended June 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $20,625. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022. F2: The options became fully vested on the date the Plan amendment was approved by the registrant's stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The option grant was approved by the registrant's board of directors on August 10, 2023, subject to stockholder approval of an amendment to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the "Plan") under which the option was granted. The registrant's stockholders approved the Plan amendment on August 31, 2023.
F2: The options became fully vested on the date the Plan amendment was approved by the registrant's stockholders.
F3: In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended June 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $20,625. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022.
Decoy Therapeutics Inc.
Report date July 25, 2018 · Filed July 26, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.82 · Expires 2028-07-25 | Direct | 10,000 |
Reported balance
After 2018-07-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-07-25 · Grant · Acquired 10,000 · Balance 10,000 F1: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018.
TELEFLEX INC
Report date June 07, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,187 |
Ending reported balance
After 2026-06-08 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-06-07 · Tax withholding · Disposed 4,054 · Balance 15,529 F1: Shares withheld to satisfy tax liability upon vesting of restricted stock unit award. Row 2 · 2026-06-08 · Grant · Acquired 995 · Balance 16,524 F2: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"). Row 3 · 2026-06-08 · Grant · Acquired 4,663 · Balance 21,187 F3: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting. |
| Stock Option / (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $131.74 · Expires 2036-06-08 | Direct | 2,192 |
Reported balance
After 2026-06-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-08 · Grant · Acquired 2,192 · Balance 2,192 F4: Stock Option Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld to satisfy tax liability upon vesting of restricted stock unit award.
F2: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
F3: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting.
F4: Stock Option Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QXO BUILDING PRODUCTS, INC.
Report date April 29, 2025 · Filed April 29, 2025
Section 16 reporting ended · disclosed 2025-04-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-04-29 transaction · row 1
1 source rowRow 1 · 2025-04-29 · Disposition to issuer · Disposed 25,970 · Balance 0 F1: Pursuant to an Agreement and Plan of Merger dated as of March 20, 2025 (the "Merger Agreement") by and among Beacon Roofing Supply, Inc. (the "Company"), QXO, Inc. ("QXO") and Queen MergerCo, Inc., a wholly owned subsidiary of QXO (the "Merger Sub"), the Merger Sub merged with and into the Company. Pursuant to the terms of the Merger Agreement, each share of Common Stock of the Company held by the Reporting Person was converted into the right to receive $124.35 in cash. |
| Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-04-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-04-29 · Disposition to issuer · Disposed 16,489 · Balance 0 F2: Each RSU represented a contingent right to receive one (1) share of Common Stock of the Company. F3: Pursuant to the terms of the Merger Agreement, each vested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. All such RSUs were fully vested prior to the date of the Merger Agreement, with retirement from the board the sole condition to settlement. |
| Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security · Expires 2025-05-15 | Direct | 0 |
Reported balance
After 2025-04-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-04-29 · Disposition to issuer · Disposed 1,400 · Balance 0 F2: Each RSU represented a contingent right to receive one (1) share of Common Stock of the Company. F4: Pursuant to the terms of the Merger Agreement, each unvested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. The RSUs were scheduled to vest on the date referenced in column 6. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an Agreement and Plan of Merger dated as of March 20, 2025 (the "Merger Agreement") by and among Beacon Roofing Supply, Inc. (the "Company"), QXO, Inc. ("QXO") and Queen MergerCo, Inc., a wholly owned subsidiary of QXO (the "Merger Sub"), the Merger Sub merged with and into the Company. Pursuant to the terms of the Merger Agreement, each share of Common Stock of the Company held by the Reporting Person was converted into the right to receive $124.35 in cash.
F2: Each RSU represented a contingent right to receive one (1) share of Common Stock of the Company.
F3: Pursuant to the terms of the Merger Agreement, each vested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. All such RSUs were fully vested prior to the date of the Merger Agreement, with retirement from the board the sole condition to settlement.
F4: Pursuant to the terms of the Merger Agreement, each unvested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. The RSUs were scheduled to vest on the date referenced in column 6.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2017 Filed Feb 14, 2017 17:42 UTC | QXO BUILDING PRODUCTS, INC. BECN · Entity 80418 | GrantRestricted Stock Units (RSUs) · Derivative | 1,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002374 · edgar.xml · derivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987 Underlying: Common Stock, $0.01 par value · 1,987 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of BECN common stock. F2 · derivative.exercise_date: Restricted Stock Units vest and settle on the first anniversary of the date of grant. F2 · derivative.expiration_date: Restricted Stock Units vest and settle on the first anniversary of the date of grant. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 16:28 UTC | QXO BUILDING PRODUCTS, INC. BECN · Entity 80418 | Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 2,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002246 · edgar.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 par value · 2,657 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one for one basis. F2 · derivative.exercise_date: On February 9, 2016, the reporting individual was granted restricted stock units which vested and settled on the one year anniversary of the grant date. F2 · derivative.expiration_date: On February 9, 2016, the reporting individual was granted restricted stock units which vested and settled on the one year anniversary of the grant date. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 16:28 UTC | QXO BUILDING PRODUCTS, INC. BECN · Entity 80418 | Exercise / conversionCommon stock, $.01 par value | 2,657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-002246 · edgar.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one for one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.